Enantiomerically pure (1 R,1‘ R )-1,3-bis[1-(diphenylphosphino)ethyl]benzene ( 4 ) has been obtained for the first time. The key step involves in situ tosylation of chiral (1 S,1‘ S )-dimethyl-1,3-benzenedimethanol ( 6 ) followed by nucleophilic attack with LiPPh 2 (BH 3 ) to give [(1 R,1‘ R )-1,3-bis[1-(diphenylphosphino)ethyl]benzene]−bisborane ( 7 ). The bisborane-protected phosphine can be easily handled and purified before deprotecting with HBF 4 ·OMe 2 to give the title compound. [(1 R,1‘ R )-2,6-bis[1-(diphenylphosphino)ethyl]phenyl]chloropalladium(II) ( 9 ) and the platinum(II) analogue ( 8 ) were synthesized through reaction of the chiral PCP-type ligand with PdCl 2 (PhCN) 2 and [Pt 2 (μ-Cl) 2 (η 3 -CH 2 C(CH 3 )CH 2 ) 2 ], respectively, and their X-ray crystal structures were determined. Removal of chloride with AgOTf provided an active catalyst species for the asymmetric aldol reaction of methyl isocyanoacetate and aldehydes.
No takes yet. Share an insight, caveat, or question.
Longmire et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: